aser Therapy for Lymphedema: Feasibility Trial
- Conditions
- Breast Cancer-Related LymphedemaPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationCancer - BreastCardiovascular - Diseases of the vasculature and circulation including the lymphatic system
- Registration Number
- ACTRN12616001126404
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 20
Participants are eligible if they (1) are women over 18 years old; (2) are referred/attending for breast cancer-related lymphedema treatment at the Department of Physiotherapy in Dunedin Hospital; (3) are able to communicate in English/Mandarin.
Exclusion criteria include: (1) presence of active or suspected metastases; (2) previous attendance for intravenous chemotherapy or radiation therapy in the last 3 months; (3) history of severe trauma/surgery to the arms; (4) occurrence of any acute infection in the arms (e.g. cellulitis) in the last 3 months; (5) photosensitivity; (6) use of laser therapy for lymphedema in the last 3 months; (7) use of medications that affect body fluid (e.g. diuretics) in the last 3 months; (8) postpartum, pregnancy or intended pregnancy; (9) severe psychological disorder or dementia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method